WHAT´S NEW in Spondyloarthritis?
In this section you will be able to identify the new content uploaded regularly .
The Importance of addressing muscloskeletal signs & symptoms in psoriatic arthritis
Prof. William Tillett
Consultant rheumatologist, royal national hospital for rheumatic diseases senior lecturer, pharmacy and pharmacology, University of Bath, UK
The Role of JAKs in SpA
Prof. Eduardo Mysler
Director of the medical research organization, principal investigator and clinical protocol designer for medical institutions, OMI in Buenos Aires, Argentina
Upadacitinib for Active Psoriatic Arthritis Refractory to Biologics (SELECT-PSA 2)
Prof. Philip Mease
Swedish medical center/ Providence St Joseph Health and university of Washington, Seattle, Washington
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis (SELECT-PSA 1)
Prof. Ian Mclnnes
University of Glasgow